Error message

The page you requested does not exist. For your convenience, a search was performed using the query Infectious Diseases Vaccines.

Page not found

Search results

  1. Meet with… NCI

    as a deputy director in the foundation's Global Health Program, Infectious Disease, where he was central ... innovation across five platforms- vaccines, drugs, diagnostics, devices, and system and service innovations- ... and deliver safe, effective, and affordable treatments for neglected diseases, and the Devices and Tools ...

  2. Investor Spotlight: Debiopharm

    and decision support systems. Solutions should be applicable in oncology or infectious diseases, the focus ... with early stage programs in oncology and infectious diseases (preferably 18 months from IND) and diagnostic ... Innovative technology Fit with Debiopharm Group’s interests (applicability to oncology or infectious disease ...

  3. Cancer Awareness Day at JLABS @ SSF

    infectious diseases, vaccines and biologics on the west coast. Prior to that she was at Roche Partnering ...

  4. Longitude Prize Panel

    of Infectious Diseases, Sharp Memorial Hospital read more» Tamar Ghosh | Lead, Longitude Prize, NESTA read more» ... | Department of Infectious Diseases, Sharp Healthcare; Associate Adjunct Professor, Division of Host-Microbe ... George Sakoulas, MD, is an active infectious diseases clinician at Sharp Memorial Hospital in San Diego ...

  5. Investor Spotlight: Debiopharm

    and decision support systems. Solutions should be applicable in oncology or infectious diseases, the focus ... with early stage programs in oncology and infectious diseases (preferably 18 months from IND) and diagnostic ... Innovative technology Fit with Debiopharm Group’s interests (applicability to oncology or infectious disease ...

  6. Investor Spotlight: Debiopharm

    and decision support systems. Solutions should be applicable in oncology or infectious diseases, the focus ... with early stage programs in oncology and infectious diseases (preferably 18 months from IND) and diagnostic ... Innovative technology Fit with Debiopharm Group’s interests (applicability to oncology or infectious disease ...

  7. Investor Spotlight: Debiopharm

    and decision support systems. Solutions should be applicable in oncology or infectious diseases, the focus ... with early stage programs in oncology and infectious diseases (preferably 18 months from IND) and diagnostic ... Innovative technology Fit with Debiopharm Group’s interests (applicability to oncology or infectious disease ...

  8. Science 1st- Oncology: Harnessing Cancer Immunotherapies of the Future

    of Technology read bio» Wendy Garrett | Associate Professor, Immunology & Infectious Diseases, Harvard T. H. ... of the Infectious Disease Interdisciplinary Research Group of Singapore-MIT Alliance for Research and Technology ... list ^ Wendy Garrett, M.D., Ph.D. | Associate Professor, Immunology & Infectious Diseases, Harvard ...

  9. Cancer Awareness Day at JLABS @ SSF

    in oncology, immunology, infectious diseases, vaccines and biologics on the west coast. Prior to that she ... Mandell studying neuroinflammation in injury and disease. Prior to founding OncoSynergy, he started ... in oncology, rare diseases and other specialty therapeutic areas. He currently serves on the boards ...

  10. Cancer Awareness Day at JLABS @ SSF

    in oncology, immunology, infectious diseases, vaccines and biologics on the west coast. Prior to that she ... Mandell studying neuroinflammation in injury and disease. Prior to founding OncoSynergy, he started ... in oncology, rare diseases and other specialty therapeutic areas. He currently serves on the boards ...

Pages

Share